Adenosine diphosphate inhibits the serotonin transporter

Abstract

Adenosine 5′-diphosphate (ADP) caused rapid and significant reductions in the rates of [ 3H]serotonin uptake observed for human platelets, human platelet vesicles, and rat brain synaptic vesicles. Estimated V max values in platelets ( N = 15), platelet vesicles ( N = 3), and synaptic vesicles ( N = 3) exposed to 100 μM ADP were 42.3 ± 11.4%, 78.8 ± 1.4%, and 56.8 ± 9.9% of control values, respectively. The EC 50 values observed for ADP in platelets and platelet vesicles were 10–24 μM. Exposure to 100 μM ADP had small, inconsistent effects on K M values observed for the platelet transporter. ADP (100 μM) caused only a slight competitive inhibition of the platelet membrane binding of [ 3H]citalopram, a ligand for the 5HT uptake site of the transporter (5.0% displacement of 1.0 nM [ 3H]citalopram, 13% increase in apparent K D). The ADP analogue 2-methylthioADP caused similar decreases in the rates of platelet [ 3H]serotonin uptake, while a number of other related compounds had little or no effect on rates of platelet uptake. The ADP-effect on uptake was rapid, occurring in less than 2.5 s, and was additive with reductions produced by protein kinase C (PKC) activation. The ADP-induced decreases in uptake did not appear to occur through the ADP receptor or known platelet second messenger systems. The exact mechanism of the ADP-effect and its functional significance remain to be determined.